Skip to content

Clinical trials

Rheumatic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rheumatic Diseases Clear all

251 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20023
20031
20042
20052
20064
20074
20082
200912
20106
20115
20127
20136
20149
20159
20169
20179
201814
201910
202022
202123
202222
202311
202421
202517
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed132
Unknown status48
Recruiting27
Terminated17
Not yet recruiting11
Active, not recruiting7
Withdrawn6
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Medical Sciences and Nutrition, Salvador Zubiran5
Novartis Pharmaceuticals5
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)4
Regeneron Pharmaceuticals4
University of Alabama at Birmingham4
University of Sao Paulo4
Amgen3
Assiut University3
Cairo University3
Istanbul University - Cerrahpasa3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rheumatic Diseases251
Arthritis61
Arthritis, Rheumatoid56
Joint Diseases52
Musculoskeletal Diseases51
Osteoarthritis34
Autoimmune Diseases28
Osteoarthritis, Knee19
Lupus Erythematosus, Systemic17
COVID-1916

Trials

Showing 26 to 50 of 251. Each trial links to its page on Pharma Observatory.

151 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.